Clinical Trial

CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA)

Study acronym: CARE-CCTA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the use of CaRi-Heart® analysis, an artificial-intelligence (AI) software tool that measures inflammation in the coronary arteries using images already captured during a standard Coronary CT Angiography (CCTA) exam. The goal is to determine whether the additional information provided by CaRi-Heart® changes clinical decision-making and helps improve early identification and management of coronary artery disease in community imaging centers. Patients who undergo CCTA as part of their regular care will be invited to have their scans analyzed using CaRi-Heart® at no extra cost, time, or radiation.
Trial Details
NCT Number NCT07220304
Lead Sponsor Corazon Medical PC
Conditions Coronary Artery Disease, Atherosclerosis, Cardiovascular Inflammation
Enrollment 15,000 participants
Start Date 2025-12
Primary Completion 2028-01 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2025-10-23